RE: Rebs438 . The sp is ridicuously low IMHO. The Molecular Analysis Plc's **MUST**29 Jan 2024 22:40
Any newbies looking in would do well to ignore our resident moron on this board aka twogoodto die.
Read the recent RNSs and make your own mind up. Company is funded through to Q2 2025, trebling revenues this year, and imposed stringent cost cutting measures. Also now in a promising partnership with a 4bn Japanese pharma co with follow on deals very much on the table. Buy out candidate imo.
Quite frankly the SP has retraced to the price reversal zone and is poised to now go higher. Next news potentially explosive.